Skip to Main Content
Pharmacy Technician's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • National Certification
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Infectious Diseases
  4. HIV & AIDS
  5. Treatment

Treatment

  • Antimicrobial Stewardship (19)
  • Avian Influenza (Bird Flu) (1)
  • COVID-19 (35)
  • Fever (5)
  • Fungal Infections (9)
  • H1N1 (Swine) Influenza (56)
  • HIV & AIDS (56)
    • Drug-Induced Toxicity (5)
    • Drug Interactions (9)
    • HIV Screening and Testing (10)
    • Opportunistic Infection Drug Therapies (3)
    • Prevention (31)
    • Treatment (18)
      • Antiviral Drug Therapies (15)
      • Selecting a Treatment Regimen (14)
  • Infections (60)
  • Lower Respiratory Tract Infections (122)
  • Measles (2)
  • MRSA (6)
  • Other (173)
  • Resources (499)
  • STIs (97)
  • Skin/Soft Tissue Infections (71)
  • Thrush (1)
  • Travel Medicine (61)
  • Upper Respiratory Tract Infections (190)
  • Vaccines (285)
  • West Nile Virus (10)
1 - 15 of 18 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: New Drugs: Vocabria (Cabotegravir) and Cabenuva (Cabotegravir/Rilpivirine) March 2021
Article: Watch for Cabenuva, a New Monthly Injectable for HIV March 2021
Article: Watch for Dovato, a New Combo Med for HIV July 2019
Chart: Primary Prophylaxis of Opportunistic Infections in HIV June 2019
Article: Expect to See More HIV Meds Containing "Integrase Inhibitors" October 2018
Guideline: Use of Antiretroviral Agents for Adults with HIV (Summary; HHS) (2018) October 2018
Article: Biktarvy Will Join Other Combo Meds for Treating HIV June 2018
Chart: New Drug: Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) June 2018
Guideline: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, 2018 June 2018
Checklist: HIV Patient Transitions of Care Checklist May 2017
Article: Watch for HIV Patients Getting Both the Old and New Forms of Tenofovir September 2016
Other: General Principles of HIV Drug Therapy for Pharmacy Technicians September 2016
Other: HIV Drug Therapy Update for Pharmacy Technicians September 2016
Other: HIV Drug Therapy Update for Pharmacy Technicians October 2015
Article: Watch for Supplements That can Derail HIV Therapy October 2015
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved